Sign inGet started

Ragan Paula

Insider CIK 1769914 · XFOR President and CEO, Director · CAMP Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CAMP Camp4 Therapeutics Corp A Award deriv2025-06-252025-06-279,000— $09,000SEC↗
XFOR X4 Pharmaceuticals, Inc A Award2025-02-122025-02-142,250,000— $03,337,386SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2025-01-242025-01-2776,473$0.45 $34.4K1,087,386SEC↗
XFOR X4 Pharmaceuticals, Inc A Award2025-01-232025-01-27169,940— $01,163,859SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2024-11-152024-11-1931,897$0.39 $12.4K993,919SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2024-10-152024-10-1631,897$0.56 $17.9K1,025,816SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2024-10-072024-10-08239,436$0.55 $131.7K1,057,713SEC↗
XFOR X4 Pharmaceuticals, Inc A Award2024-10-042024-10-08532,081— $01,297,149SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2024-03-112024-03-1149,678$0.88 $43.7K765,068SEC↗
XFOR X4 Pharmaceuticals, Inc A Award deriv2024-02-132024-02-161,189,578— $01,189,578SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2024-02-122024-02-1221,695$1.01 $21.9K814,746SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2023-11-032023-11-0339,906$0.90 $35.9K836,441SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2023-11-012023-11-03199,531$0.73 $145.7K876,347SEC↗
XFOR X4 Pharmaceuticals, Inc A Award2023-10-312023-11-02532,081— $01,075,878SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2023-06-232023-06-266,724$1.92 $12.9K543,797SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2023-06-152023-06-166,724$2.23 $15.0K550,521SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2023-05-312023-05-316,292$1.95 $12.3K557,245SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2023-03-102023-03-1349,678$0.84 $41.7K563,537SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2023-02-132023-02-1521,695$0.93 $20.2K613,215SEC↗
XFOR X4 Pharmaceuticals, Inc A Award deriv2022-11-072022-11-093,438,335— $03,438,335SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2022-08-172022-08-1913,448— $0634,910SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2022-06-242022-06-276,724— $0648,358SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2022-06-162022-06-176,724— $0655,082SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2022-06-032022-06-066,292$1.21 $7.6K661,806SEC↗
XFOR X4 Pharmaceuticals, Inc A Award2022-03-012022-03-01220,789— $0668,098SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2022-02-112022-02-1421,695— $0447,309SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2021-08-172021-08-1913,448$5.10 $68.6K469,004SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2021-07-152021-07-1613,448$5.78 $77.7K482,452SEC↗
XFOR X4 Pharmaceuticals, Inc A Award2021-06-232021-06-2544,826— $0495,900SEC↗
XFOR X4 Pharmaceuticals, Inc A Award2021-06-152021-06-1744,826— $0451,074SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2021-06-022021-06-022,400$9.50 $22.8K406,248SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2021-06-012021-06-024,104$9.41 $38.6K408,648SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2021-05-032021-05-042,400$8.33 $20.0K412,752SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2021-04-052021-04-072,400$9.17 $22.0K415,152SEC↗
XFOR X4 Pharmaceuticals, Inc A Award2021-03-242021-03-25144,629— $0417,552SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2021-03-022021-03-022,400$9.74 $23.4K272,923SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2021-02-022021-02-032,400$7.88 $18.9K275,323SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2021-01-052021-01-062,400$7.00 $16.8K277,723SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2020-12-232020-12-284,800$7.00 $33.6K280,123SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2020-10-052020-10-061,797$7.00 $12.6K284,923SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2020-10-022020-10-05603$7.00 $4.2K286,720SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2020-09-092020-09-108,840$8.04 $71.1K287,323SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2020-09-022020-09-032,400$7.99 $19.2K296,163SEC↗
XFOR X4 Pharmaceuticals, Inc A Award2020-08-172020-08-1844,825— $0298,563SEC↗
XFOR X4 Pharmaceuticals, Inc A Award2020-08-142020-08-1844,826— $0253,738SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2020-08-032020-08-042,400$7.45 $17.9K208,912SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2020-07-022020-07-062,400$9.05 $21.7K211,312SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2020-06-032020-06-039,707$8.88 $86.2K213,712SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2020-06-022020-06-032,400$8.65 $20.8K223,419SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2020-06-012020-06-034,275$8.63 $36.9K225,819SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2020-05-042020-05-052,400$8.92 $21.4K230,094SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2020-04-022020-04-032,400$8.40 $20.2K232,494SEC↗
XFOR X4 Pharmaceuticals, Inc S Sale2020-03-022020-03-032,400$10.64 $25.5K234,894SEC↗
XFOR X4 Pharmaceuticals, Inc A Award deriv2019-06-172019-06-1983,893— $083,893SEC↗
XFOR X4 Pharmaceuticals, Inc A Award2019-06-172019-06-1955,928— $0237,294SEC↗
XFOR X4 Pharmaceuticals, Inc A Award deriv2019-03-132019-03-1465,430— $065,430SEC↗
XFOR X4 Pharmaceuticals, Inc A Award deriv2019-03-132019-03-1480,160— $080,160SEC↗
XFOR X4 Pharmaceuticals, Inc A Award deriv2019-03-132019-03-14100,729— $0100,729SEC↗
XFOR X4 Pharmaceuticals, Inc A Award2019-03-132019-03-14181,366— $0181,366SEC↗